Entering text into the input field will update the search result below

Moderna leads with antibody response in COVID-19 booster trial in U.K.

Dec. 03, 2021 6:49 AM ETModerna, Inc. (MRNA), AZN, PFE, BNTXVALNBy: Dulan Lokuwithana, SA News Editor49 Comments

Booster shot covid-19 vaccine concept

Wachiwit/iStock via Getty Images

  • According to a peer-reviewed study published in The Lancet on Thursday, Moderna (NASDAQ:MRNA) COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.
  • The Phase 2 "COV-Boost" study

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.